Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA289744
Max Phase: Preclinical
Molecular Formula: C44H54N8O9
Molecular Weight: 838.96
Molecule Type: Small molecule
Associated Items:
ID: ALA289744
Max Phase: Preclinical
Molecular Formula: C44H54N8O9
Molecular Weight: 838.96
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C(=O)[C@H](CCCCNC(=O)/C=C/c1cccnc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C44H54N8O9/c1-44(2,3)61-43(60)51-35(24-30-27-48-32-17-9-8-16-31(30)32)40(57)49-33(18-10-11-22-47-37(53)20-19-29-15-12-21-46-26-29)42(59)52(4)36(25-38(54)55)41(58)50-34(39(45)56)23-28-13-6-5-7-14-28/h5-9,12-17,19-21,26-27,33-36,48H,10-11,18,22-25H2,1-4H3,(H2,45,56)(H,47,53)(H,49,57)(H,50,58)(H,51,60)(H,54,55)/b20-19+/t33-,34-,35?,36-/m0/s1
Standard InChI Key: INPUMSDGOIKULR-GRXOVFRMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 838.96 | Molecular Weight (Monoisotopic): 838.4014 | AlogP: 3.00 | #Rotatable Bonds: 21 |
Polar Surface Area: 255.01 | Molecular Species: ACID | HBA: 9 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.10 | CX Basic pKa: 4.91 | CX LogP: 1.48 | CX LogD: -0.70 |
Aromatic Rings: 4 | Heavy Atoms: 61 | QED Weighted: 0.05 | Np Likeness Score: -0.22 |
1. Bennett MJ, Nikkel AL, Bianchi BR, Miller TR, Bednarz L, Witte DG, Stashko M, Wang SS, Gore PA, Asin KE.. (1994) CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue., 37 (11): [PMID:8201591] [10.1021/jm00037a006] |
Source(1):